Can the sequence of chemotherapy regimens influence outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)?

被引：1
|
作者：
Schmidt, Shannon Leah
Durkal, Vipal
Jayavalsan, Shinoj Pattali
Ritch, Paul S.
Thomas, James P.
Erickson, Beth
Christians, Kathleen K.
Tsai, Susan
Evans, Douglas B.
George, Ben
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Froedtert Hosp, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
    Fonseca de Jesus, Victor Hugo
    Guedes Camandaroba, Marcos Pedro
    Spina Donadio, Mauro Daniel
    Cabral, Audrey
    Muniz, Thiago Pimentel
    Leite, Luciana de Moura
    Sant'Ana, Lucas Ferreira
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (04) : 694 - 707
  • [22] Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma
    Reni, M.
    Zanon, S.
    Balzano, G.
    Nobile, S.
    Pircher, C. C.
    Chiaravalli, M.
    Passoni, P.
    Arcidiacono, P. G.
    Nicoletti, R.
    Crippa, S.
    Slim, N.
    Doglioni, C.
    Falconi, M.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2786 - 2792
  • [23] Paricalcitol addition to chemotherapy in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PINBALL)
    Propper, David
    Jameson, Gayle
    Roe, Denise
    Wertheim, Betsy
    Von Hoff, Dan
    Borazanci, Erkut H.
    CANCER RESEARCH, 2024, 84 (07)
  • [24] Outcomes in metastatic pancreatic adenocarcinoma (MPAC) patients treated with FOLFIRINOX (FFX)/FOLFOX(FX) and gemcitabine plus nab-paclitaxel (NabG).
    Schmidt, Shannon Leah
    Durkal, Vipal
    Jayavalsan, Shinoj Pattali
    Thomas, James P.
    Ritch, Paul S.
    Erickson, Beth
    Christians, Kathleen K.
    Tsai, Susan
    Evans, Douglas B.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [25] Survival for Patients with Radiographically Occult Metastatic Pancreatic Adenocarcinoma in the Era of Modern Multiagent Chemotherapy
    Eckhoff, Austin
    Kanu, Elishama
    Aykut, Berk
    Bao, Matthew
    Blazer, Dan G., III
    Zani, Sabino
    Lidsky, Michael E.
    Allen, Peter J.
    Nussbaum, Daniel P.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S108 - S108
  • [26] Can anemia influence the outcome in colorectal cancer patients on chemotherapy?
    Proietti, E.
    Cerbone, L.
    Zivi, A.
    Rosati, M.
    Restuccia, M.
    Ricciardi, S.
    Raimondi, C.
    Longo, F.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII84 - VII85
  • [27] Quality of life (QoL) of patients (pts) with metastatic pancreatic cancer (mPAC) initiating first-line chemotherapy (CT) in routine practice
    Laquente, B.
    Macarulla, T.
    Buges, C.
    Martin, M.
    Garcia, C.
    Dotor, E.
    Merino, S.
    Visa, L.
    Martin, T.
    Pedraza, M.
    Guardeno, R.
    Pellin, L.
    Vilanova, D.
    Garcia, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
    Kieler, Markus
    Unseld, Matthias
    Bianconi, Daniela
    Schindl, Martin
    Kornek, Gabriela V.
    Scheithauer, Werner
    Prager, Gerald W.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [29] Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma
    Springfeld, Christoph
    Wiecha, Christiane
    Kunzmann, Romy
    Heger, Ulrike
    Weichert, Wilko
    Langer, Rupert
    Stange, Annika
    Blank, Susanne
    Sisic, Leila
    Schmidt, Thomas
    Lordick, Florian
    Jaeger, Dirk
    Grenacher, Lars
    Bruckner, Tom
    Buechler, Markus W.
    Ott, Katja
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S905 - S914
  • [30] Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma
    Christoph Springfeld
    Christiane Wiecha
    Romy Kunzmann
    Ulrike Heger
    Wilko Weichert
    Rupert Langer
    Annika Stange
    Susanne Blank
    Leila Sisic
    Thomas Schmidt
    Florian Lordick
    Dirk Jäger
    Lars Grenacher
    Tom Bruckner
    Markus W. Büchler
    Katja Ott
    Annals of Surgical Oncology, 2015, 22 : 905 - 914
12345